NXTS: SEC Form 4 filed by Nexentis Technologies Inc.
Stocks in this Quantisnow insightIndustrials
Full content unavailable. See the original source below.
Historical context for NXTS
Across the 13 sessions after earlier NXTS headlines, the stock closed higher 8 times and lower 5 times, with a median move of 6.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | NXTS | SPY |
|---|---|---|---|
| Oct 12, 2026 | Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis | -11.9% | -0.1% |
| Oct 7, 2026 | Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud | -22.3% | -0.2% |
| Sep 24, 2026 | Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board | +0.3% | -0.1% |
| Sep 23, 2026 | Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery | +3.2% | -0.7% |
| Jul 28, 2026 | Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign | -7.2% | +0.2% |
| Jul 7, 2026 | Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative | +1.6% | -0.5% |
Earlier insider filings at NXTS
- Mar 26, 2026SEC Form 4 filed by Lee Eun Young
Keep researching NXTS
- NXTS insider tradesEvery buy and sale reported by Nexentis Technologies Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- NXTS financial statementsRevenue, profit, cash flow and balance sheet from Nexentis Technologies Inc.'s SEC filings.
Quantisnow market dataNASDAQ
NXTS
Nexentis Technologies Inc.
- Market cap
- 30-day
- Sector
- Industrials
- Industry
- Agricultural Chemicals
Get push alerts for NXTS
Full NXTS profile on Quantisnow Follow NXTS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time